Investing.com - Vertex reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Vertex announced earnings per share of $3.56 on revenue of $1.98B. Analysts polled by Investing.com anticipated EPS of $3.08 on revenue of $1.86B.
Vertex shares are down 23% from the beginning of the year , still down 25.46% from its 52 week high of $242.90 set on Monday, January 25, 2021. They are under-performing the S&P 500 which is up 23.31% year to date.
Vertex follows other major Healthcare sector earnings this month
Vertex's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday, October 27, 2021 with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.38B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar